Laboratory Corporation of America Holdings
NYSE:LH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
192.5
232.56
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Laboratory Corporation of America Holdings
Intrinsic Value
Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. [ Read More ]
The intrinsic value of one
LH
stock under the Base Case scenario is
228.17
USD.
Compared to the current market price of 210.9 USD,
Laboratory Corporation of America Holdings
is
Undervalued by 8%.
Laboratory Corporation of America Holdings's market capitalization is 17.8B USD.
LH stock price is 210.9 USD.
LH stock price (210.9 USD) is 8% less than its Intrinsic Value (228.17 USD).
LH stock price (210.9 USD) is 28% less than its Relative Value (293.43 USD). Open Relative Valuation
LH has positive Net Income for the last twelve months.
LH has positive three-year average ROIC (Return on Invested Capital): 11%. The company is efficient at using invested capital to generate operating income.
LH's Revenue is forecast to grow at a rate of 6% per year over the next 3 years.
LH's Revenue has dropped by 7% over the past 12 months.
LH's ROE (Return on Equity) for the past 12 months is very low and is equal to 5%.
LH's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 4%.
LH has positive Operating Income for the last twelve months.
LH's short-term liabilties (4B USD) exceed its short-term assets (3B USD).
LH's Revenue has been falling by 7% per year for the last 3 years.
LH has positive three-year average ROE (Return on Equity): 17%. The company is efficient at transforming stockholders' equity into net income.
LH's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 18% to 4%.
LH's Altman Z-Score is equal to 2.9.
LH has positive Gross Profit for the last twelve months.
LH has positive Free Cash Flow for the last twelve months.
LH's ROE (Return on Equity) has significantly decreased in the last 3 years from 33% to 5%.
LH's long-term assets (17B USD) exceed its long-term liabilties (9B USD).
LH's D/E (Debt to Equity) is very low and is equal to 0.39.
LH has positive Net Debt. This means that the company has more debt (3B USD) than cash and short-term investments (99m USD).
LH generates enough operating income (1B USD) to cover interest payments on its debt (223m USD).
Valuation Backtest
Laboratory Corporation of America Holdings
Run backtest to discover the historical profit from buying and selling
LH
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Laboratory Corporation of America Holdings
| Current Assets | 3.5B |
| Cash & Short-Term Investments | 99.3m |
| Receivables | 2.2B |
| Other Current Assets | 1.2B |
| Non-Current Assets | 13.1B |
| Long-Term Investments | 17.7m |
| PP&E | 2.9B |
| Intangibles | 9.6B |
| Other Non-Current Assets | 546m |
| Current Liabilities | 3.9B |
| Accounts Payable | 695.5m |
| Accrued Liabilities | 820.6m |
| Other Current Liabilities | 2.4B |
| Non-Current Liabilities | 4.6B |
| Long-Term Debt | 3.1B |
| Other Non-Current Liabilities | 1.5B |
Earnings Waterfall
Laboratory Corporation of America Holdings
|
Revenue
|
12.3B
USD
|
|
Cost of Revenue
|
-8.9B
USD
|
|
Gross Profit
|
3.4B
USD
|
|
Operating Expenses
|
-2.3B
USD
|
|
Operating Income
|
1.1B
USD
|
|
Other Expenses
|
-679.9m
USD
|
|
Net Income
|
433.1m
USD
|
Free Cash Flow Analysis
Laboratory Corporation of America Holdings
| USD | |
| Free Cash Flow | USD |
LH Profitability Score
Profitability Due Diligence
Laboratory Corporation of America Holdings's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Laboratory Corporation of America Holdings's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
LH Solvency Score
Solvency Due Diligence
Laboratory Corporation of America Holdings's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Score
Laboratory Corporation of America Holdings's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LH Price Targets Summary
Laboratory Corporation of America Holdings
According to Wall Street analysts, the average 1-year price target for
LH
is 244.51 USD
with a low forecast of 212.1 USD and a high forecast of 275.1 USD.
Click here to dive deeper.
Ownership
LH Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Price Appreciation
LH Price
Laboratory Corporation of America Holdings
| Average Annual Return | 12.1% |
| Standard Deviation of Annual Returns | 28.1% |
| Max Drawdown | -47% |
| Market Capitalization | 17.8B USD |
| Shares Outstanding | 84 290 000 |
| Percentage of Shares Shorted | 3.06% |
Company Profile
Laboratory Corporation of America Holdings
Country
Industry
Market Cap
Dividend Yield
Description
Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 75,500 full-time employees. The Company’s business segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). Through its Dx and DD segments, the Company provides diagnostic, drug development and technology enabled solutions. The firm also supports clinical trial activity in approximately 100 countries through its industry central laboratory, preclinical, and clinical development businesses. Dx segment operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. DD segment, which operates on a global scale. The firm serves a range of customers, including doctors, hospitals, pharmaceutical companies, researchers, governmental agencies, physicians and other healthcare providers. The company also helps in delivering non-clinical testing services.
Contact
IPO
Employees
Officers
The intrinsic value of one
LH
stock under the Base Case scenario is
228.17
USD.
Compared to the current market price of 210.9 USD,
Laboratory Corporation of America Holdings
is
Undervalued by 8%.
You don't have any saved screeners yet
